PL206281A1 - Sposob wytwarzania auranofiny - Google Patents

Sposob wytwarzania auranofiny

Info

Publication number
PL206281A1
PL206281A1 PL20628178A PL20628178A PL206281A1 PL 206281 A1 PL206281 A1 PL 206281A1 PL 20628178 A PL20628178 A PL 20628178A PL 20628178 A PL20628178 A PL 20628178A PL 206281 A1 PL206281 A1 PL 206281A1
Authority
PL
Poland
Prior art keywords
auranofin
making
making auranofin
Prior art date
Application number
PL20628178A
Other languages
English (en)
Other versions
PL111162B1 (en
Inventor
David T Hill
Blaine M Sutton
Ivan Lantos
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of PL206281A1 publication Critical patent/PL206281A1/pl
Publication of PL111162B1 publication Critical patent/PL111162B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Glass Compositions (AREA)
  • Cosmetics (AREA)
PL1978206281A 1977-04-21 1978-04-21 Method of producing s-triethylophosphinogold 2,3,4,6-tetra-o-acetylo-beta-d-glycopyranosylothiol-1-ane PL111162B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,603 US4131732A (en) 1977-04-21 1977-04-21 Method for preparing auranofin

Publications (2)

Publication Number Publication Date
PL206281A1 true PL206281A1 (pl) 1979-03-12
PL111162B1 PL111162B1 (en) 1980-08-30

Family

ID=25148131

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978206281A PL111162B1 (en) 1977-04-21 1978-04-21 Method of producing s-triethylophosphinogold 2,3,4,6-tetra-o-acetylo-beta-d-glycopyranosylothiol-1-ane

Country Status (20)

Country Link
US (1) US4131732A (pl)
AR (1) AR215695A1 (pl)
AT (1) AT361507B (pl)
BG (1) BG28716A3 (pl)
CH (1) CH633561A5 (pl)
CS (1) CS194843B2 (pl)
DD (1) DD136745A5 (pl)
DK (1) DK150858C (pl)
ES (1) ES468938A1 (pl)
FI (1) FI64165C (pl)
FR (1) FR2387996A1 (pl)
IE (1) IE47046B1 (pl)
IL (1) IL54528A0 (pl)
IT (1) IT1094084B (pl)
NO (1) NO146328C (pl)
PL (1) PL111162B1 (pl)
PT (1) PT67904B (pl)
SE (1) SE444568B (pl)
SU (1) SU795486A3 (pl)
YU (1) YU39417B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301152A (en) * 1979-10-26 1981-11-17 Merck & Co., Inc. Immunologic adjuvant
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
NZ228367A (en) * 1988-03-23 1992-02-25 Smithkline Beecham Corp Topical composition containing a gold compound for treating inflammatory conditions
CN1057092C (zh) * 1997-10-31 2000-10-04 昆明贵金属研究所 金诺芬的制备方法
CA2814694C (en) * 2010-10-12 2019-01-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating giardiasis
WO2016124936A1 (en) 2015-02-06 2016-08-11 Auspherix Limited Inhibition of microbial persister cells
JP2018504434A (ja) 2015-02-06 2018-02-15 オースフェリクス・リミテッドAuspherix Limited オーラノフィンを使用してバイオフィルムを抑制及び分散する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757672A (fr) * 1969-10-28 1971-04-19 Smith Kline French Lab Complexes d'auro-trialcoylphosphine de 1-beta-D-glucopyranosides
DK135897B (da) * 1969-10-28 1977-07-11 Smith Kline French Lab Fremgangsmåde til fremstilling af trialkylphosphinguldhalogenider.
DK129847B (da) * 1969-10-28 1974-11-25 Smith Kline French Lab Analogifremgangsmåde til fremstilling af trialkylphosphinguldkomplekser af 1-β-D-glucopyranosider.

Also Published As

Publication number Publication date
DK150858B (da) 1987-07-06
IT7822402A0 (it) 1978-04-17
YU39417B (en) 1984-12-31
NO146328B (no) 1982-06-01
BG28716A3 (en) 1980-06-16
FR2387996A1 (fr) 1978-11-17
PT67904A (en) 1978-05-01
AR215695A1 (es) 1979-10-31
ES468938A1 (es) 1978-12-16
IE47046B1 (en) 1983-12-14
PT67904B (en) 1979-10-15
US4131732A (en) 1978-12-26
ATA274678A (de) 1980-08-15
SE7804208L (sv) 1978-10-22
PL111162B1 (en) 1980-08-30
NO146328C (no) 1982-09-08
DK163978A (da) 1978-10-22
FI64165B (fi) 1983-06-30
SU795486A3 (ru) 1981-01-07
NO781391L (no) 1978-10-24
SE444568B (sv) 1986-04-21
DK150858C (da) 1987-12-07
DD136745A5 (de) 1979-07-25
IE780753L (en) 1978-10-21
FR2387996B1 (pl) 1980-08-01
CS194843B2 (en) 1979-12-31
CH633561A5 (de) 1982-12-15
FI781155A (fi) 1978-10-22
FI64165C (fi) 1983-10-10
YU95478A (en) 1982-10-31
IT1094084B (it) 1985-07-26
IL54528A0 (en) 1978-07-31
AT361507B (de) 1981-03-10

Similar Documents

Publication Publication Date Title
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL205592A1 (pl) Sposob wytwarzania nitrozobenzenu
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL206281A1 (pl) Sposob wytwarzania auranofiny
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych
PL201824A1 (pl) Sposob wytwarzania m-benzoiloacetofenonu
PL204509A1 (pl) Sposob wytwarzania nowych dwuwodorobenzopiranoksantenonow
PL202862A1 (pl) Sposob wytwarzania chloroanilin
PL207682A1 (pl) Sposob wytwarzania 3-tlenkow chinazolinonu
PL203230A1 (pl) Sposob wytwarzania tworzyw steatytowych
PL202536A1 (pl) Sposob wytwarzania tionitryli
PL195376A1 (pl) Sposob wytwarzania 3-dezacetoksycefalosporyn
PL201903A1 (pl) Sposob wytwarzania m-benzyloiloacetofenonu
PL199208A1 (pl) Sposob wytwarzania 1-trans-cynamylo-4-dwufenylo-metylopiperazyny